-
Exploiting immune cell receptor information to quantify index switching in single cell transcriptome sequencing experiment
Study
EGAS00001002911
-
A genome scan for genes underlying adult body size differences between Central African hunter-gatherers and farmers.
Study
EGAS00001002975
-
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease
Study
EGAS00001003071
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - RNA-seq
Study
EGAS00001003274
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing
Study
EGAS00001000962
-
We evaluate the potential for routine WGS using ONT by sequencing the well-characterised reference sample NA12878 and the genome of an individual with ataxia-pancytopenia syndrome accompanied by severe immune dysregulation.
Study
EGAS00001003469
-
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
Study
EGAS00001004212
-
Post_Mortem_Tissue_COVID19_RNA
Study
EGAS00001004442
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
UK10K NEURO UKSCZ
Study
EGAS00001000123
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
A reference map of potential determinants for the human serum metabolome
Study
EGAS00001004512
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
Characterization of a human iPSC-derived endocrine pancreas model
Study
EGAS00001001803
-
Breast cancer women lack normal lifelong immune response after full-term pregnancies
Study
EGAS00001002616
-
DSRCT RNA genomic sequencing
Study
EGAS00001002770
-
Post_Mortem_Tissue_COVID19_spatial
Study
EGAS00001004441
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Profiling the unique protective properties of intracranial arterial endothelial cells
Study
EGAS00001004479
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Exploration of coding and non-coding variants in cancer using GenomePaint.
Study
EGAS00001004669
-
Targeting the DNA Repair Pathway in Ewing Sarcoma
Study
EGAS00001000839
-
A molecular cell atlas of the human lung from single cell RNA sequencing
Study
EGAS00001004344
-
Are children born after medical assisted reproduction at greater risk of having an increased de novo mutation rate?
Study
EGAS00001005569
-
Persistence of circulating tumor DNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumor response
Study
EGAS00001005798
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Stromal-induced epithelial-mesenchymal transition induces drug resistance in acute lymphoblastic leukemia
Study
EGAS00001006120
-
Tracking the evolution of Therapy-Related Myeloid Neoplasms using chemotherapy signatures
Study
EGAS00001006903
-
Copy numbers in resectable gastric cancer treated with surgery alone
Study
EGAS00001007394
-
Comparison of capture-based method for transcriptome profiling of formalin-fixed paraffin embedded tumor samples
Study
EGAS00001005255
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
An analysis of humoral and cellular immune responses following COVID-19 vaccination.
Study
EGAS00001005380
-
IMCISION DNAseq
Study
EGAS00001005466
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Monocyte and macrophage lipid accumulation results in downregulated type-I interferon responses
Study
EGAS00001005955
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
Study
EGAS00001005863
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123